Latest news articles

Added 2 months ago Drug news

Sandoz initiates ROSALIA study of denosumab biosimilar.

Sandoz, a Novartis division and a global leader in biosimilars, announced the first patient enrolled in ROSALIA, an integrated Phase...

Added 2 months ago Drug news

CHMP negative for Evenity for the treatment of severe osteoporosis

Amgen and UCB announced that the companies have been informed the Committee for Medicinal Products for Human Use (CHMP) of...

Added 5 months ago Drug news

FDA approves Evenity to treat osteoporosis in postmenopausal women at high risk for fracture

Amgen and UCB announced that the FDA has approved Evenity (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at...

Search all news articles for Osteoporosis
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more

Guidelines

Management of osteoporosis and the prevention of fragility fractures

This guideline provides recommendations based on current evidence for best practice in the management of osteoporosis and prevention of fractures.

Added 4 years ago

Bone health in cancer patients: ESMO Clinical Practice Guidelines

This new ESMO guideline covers areas that make bone health in cancer patients of increasing clinical importance. Besides describing incidence, epidemiology and clinical consequences of bone metastases...

Added 5 years ago

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis.

Added 7 years ago

Search all guidelines for Osteoporosis
 

Journal articles

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.

Background: Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation, and decreases bone resorption.

Added 2 years ago

Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial

As men age, they experience decreased serum testosterone concentrations, decreased bone mineral density, and increased risk of fracture.

Added 2 years ago

Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.

Treatment with zoledronic acid in osteoporotic patients with spinal fusion shortens the duration of time to fusion, improves the fusion...

Added 3 years ago

Search all journal articles for Osteoporosis